Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical results on angiogenesis inhibitor from NeXstar

Nov. 8, 1996

RGL protein for treatment of ras-related cancers

Nov. 8, 1996

Prizm and University of Pittsburgh receive STTR grant for antimelanoma MAb

Nov. 8, 1996

Novel tumor vaccine claimed by Boehringer Ingelheim

Nov. 8, 1996

Hormonal agents from Yamanouchi

Nov. 8, 1996

Ilex compound for malignant brain tumors licensed to Janssen

Nov. 8, 1996

New taxane series disclosed by Indena

Nov. 8, 1996

Univ. of Tokyo researchers identify new antitumor antibiotics

Nov. 8, 1996

Novel piericidin antitumor antibiotics reported by Japanese and Chinese researchers

Nov. 8, 1996

Meiji Seika discloses antitumor antibiotics

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...